The Anti-Infective Innovator Blog
Biota Pharmaceuticals Sells Antibiotic Program to Spero Therapeutics
Biota Pharmaceuticals Sells Antibiotic Program to Spero Therapeutics
The Anti-Infective Innovator Blog
Posted on
October 28, 2017
Written by Spero Therapeutics,
Genetic Engineering & Biotechnology News
